Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma
Open Access
- 19 August 2010
- journal article
- viral hepatitis
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 52 (6), 1922-1933
- https://doi.org/10.1002/hep.23898
Abstract
Hepatitis B virus (HBV) is a major etiological factor of hepatocellular carcinoma (HCC). However, the postoperative prognostic value of the virological factors assayed directly from liver tissue has never been investigated. To address this issue, 185 liver samples obtained from the noncancerous part of surgically removed HBV‐associated HCC tissues were subjected to virological analysis. Assayed factors included the amount of HBV‐DNA in the liver tissues; genotype; and the presence of the HBV precore stop codon G1896A mutation, basal core promoter A1762T/G1764A mutation, and pre‐S deletions/stop codon mutation. All virological factors and clinicopathological factors were subjected to Cox proportional hazard model analysis to estimate postoperative survival. It was found that an HBV‐DNA level >3.0 × 107 copies/g of liver tissue and the presence of the basal core promoter mutation independently predicted disease‐free (adjusted hazard ratio 1.641 [95% confidence interval (CI) 1.010‐2.667] and 2.075 [95% CI 1.203‐3.579], respectively) and overall (adjusted hazard ratio 2.807 [95% CI 1.000‐7.880] and 5.697 [95% CI 1.678‐19.342], respectively) survival. Kaplan‐Meier survival analysis indicated that in‐frame, short stretch (100 bp) pre‐S deletions, were significantly associated with poorer disease‐free (P = 0.005) and overall (P = 0.020) survival. A hot deletion region located between codons 107 and 141 of the pre‐S sequence was identified for the short stretch pre‐S deletion mutants. Conclusion: The amount of HBV‐DNA in liver tissue and the presence of the basal core promoter mutation were two independent predictors for postoperative survival in HCC. A short stretch pre‐S deletion located between codons 107 and 141 was strongly associated with a poorer postoperative prognosis. (Hepatology 2010)This publication has 33 references indexed in Scilit:
- CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infectionBMC Cancer, 2009
- Associations Between Hepatitis B Virus Mutations and the Risk of Hepatocellular Carcinoma: A Meta-AnalysisJNCI Journal of the National Cancer Institute, 2009
- Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesisHepatology, 2009
- A1762T/G1764A mutations of hepatitis B virus, associated with the increased risk of hepatocellular carcinoma, reduce basal core promoter activitiesBiochemical and Biophysical Research Communications, 2008
- Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular CarcinomaJNCI Journal of the National Cancer Institute, 2008
- Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinomaJournal of Hepatology, 2007
- The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwideJournal of Hepatology, 2006
- Proline-Directed Protein Kinase FA Is a Powerful and Independent Prognostic Predictor for Progression and Patient Survival of Hepatocellular CarcinomaJournal of Clinical Oncology, 2006
- Chronic hepatitis B in hepatocarcinogenesisHeart, 2006
- Hepatitis B Virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: A Case‐Control study in Fukuoka, JapanInternational Journal of Cancer, 1992